Study
Human FactorsRecentStrong effect

Opioid Formulation Design Impacts Patient Adherence and Treatment Efficacy

The specific release mechanisms and pharmacokinetic profiles of long-acting, extended-release, and sustained-release opioid formulations significantly influence patient adherence and the overall effectiveness of chronic pain management.

Journal of Opioid Management · 2023

01

Key Findings

  • 01Different LA, ER, and SR formulations exhibit distinct pharmacokinetic profiles.
  • 02These pharmacokinetic differences can impact the frequency of dosing, potential for dose dumping, and overall patient adherence.
  • 03The choice of formulation is critical for achieving consistent pain relief and minimizing side effects.
02

Application

Design takeaway

When designing pain management solutions, prioritize formulations that offer predictable and consistent drug release to enhance patient adherence and therapeutic success.

How to apply

When developing or selecting pain relief medications, consider the specific release profile (LA, ER, SR) and its implications for patient dosing schedules and potential for misuse or side effects.

Project actions

  • 01Consider the user's daily routine when designing medication schedules.
  • 02Explore different drug delivery mechanisms that can improve patient compliance.
03

Method & Evidence

AimHow do the pharmacological characteristics of different opioid release formulations affect patient adherence and treatment outcomes in chronic pain management?
MethodLiterature Review
ProcedureThe authors reviewed existing literature on the specific pharmacology of long-acting (LA), extended-release (ER), and sustained-release (SR) opioid formulations used for chronic nonmalignant pain.
ContextPharmaceutical design, Medical device development, Pain management

Variables

IVOpioid formulation type (LA, ER, SR)
DVPatient adherence, Treatment efficacy (pain relief, side effects)
CVPatient's chronic pain condition, Prescribed dosage, Patient's overall health status
04

Strengths & Limitations

Strengths

  • +Focuses on specific pharmacological differences between release types.
  • +Addresses a critical aspect of chronic pain management.

Limitations

The study focuses on pharmacological aspects and does not delve into the user experience design of the packaging or administration devices.

Reliability & validity

The reliability of the findings depends on the quality and consistency of the reviewed literature. Validity is enhanced by focusing on specific pharmacological mechanisms.

Think critically

Beyond the pharmacological release profile, what other design factors of opioid formulations (e.g., pill size, shape, taste, packaging) might influence patient adherence and safety?

05

Design Principles

"Formulation design should optimize the balance between therapeutic efficacy and user adherence."

Understanding the nuances of drug delivery systems is crucial for designers developing medical devices and pharmaceutical products. Tailoring formulations to specific patient needs and pain profiles can lead to improved therapeutic outcomes and reduced risk of adverse events.

06

What This Means for Your Design

How a pain pill is made to release its medicine slowly over time affects if people remember to take it and if it actually helps their pain.

How to use in your project

  • 1.Reference this study when discussing how the form factor or delivery mechanism of a medical device or pharmaceutical product can influence user interaction and outcomes.
07

Add to My Project

08

Quick Cite

(2023). Specific Pharmacology of Long-Acting, Extended-Release, and Sustained-Release Opioids for the Treatment of Chronic Nonmalignant Pain. Journal of Opioid Management. https://doi.org/10.5055/jom.2014.0230 Retrieved from https://designdex.org/study/473d600f-85f3-4646-b316-6f98c5237d58/opioid-formulation-design-impacts-patient-adherence-and-treatment-efficacy

Paragraph starter

The pharmacological characteristics of drug release formulations, such as long-acting (LA), extended-release (ER), and sustained-release (SR) opioids, significantly influence patient adherence and treatment efficacy in chronic pain management. The specific pharmacokinetic profiles of these formulations dictate dosing frequency and the potential for adverse events, underscoring the importance of formulation design in achieving desired therapeutic outcomes.

09

Source

Journal of Opioid Management

Specific Pharmacology of Long-Acting, Extended-Release, and Sustained-Release Opioids for the Treatment of Chronic Nonmalignant Pain

journal · 2023

View source

Questions about this research

What does the research say about opioid formulation design impacts patient adherence and treatment efficacy?
When designing pain management solutions, prioritize formulations that offer predictable and consistent drug release to enhance patient adherence and therapeutic success. Evidence: Journal of Opioid Management (2023).
Why does "Opioid Formulation Design Impacts Patient Adherence and Treatment Efficacy" matter for design?
Understanding the nuances of drug delivery systems is crucial for designers developing medical devices and pharmaceutical products. Tailoring formulations to specific patient needs and pain profiles can lead to improved therapeutic outcomes and reduced risk of adverse events.
How can designers apply this research?
When designing pain management solutions, prioritize formulations that offer predictable and consistent drug release to enhance patient adherence and therapeutic success.
What were the main findings?
Different LA, ER, and SR formulations exhibit distinct pharmacokinetic profiles.. These pharmacokinetic differences can impact the frequency of dosing, potential for dose dumping, and overall patient adherence.. The choice of formulation is critical for achieving consistent pain relief and minimizing side effects.
What research method was used?
Literature Review.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2023 journal from Journal of Opioid Management.
What should I do differently in my next project?
When developing or selecting pain relief medications, consider the specific release profile (LA, ER, SR) and its implications for patient dosing schedules and potential for misuse or side effects.
What are the limitations?
This review does not cover the general controversy or indications for long-term opioid therapy.
Is there evidence that pain affects design outcomes?
The way a pain medication is designed to be released over time (e.g., long-acting, extended-release) directly affects how well patients take it and how effectively it manages their pain. Understanding the nuances of drug delivery systems is crucial for designers developing medical devices and pharmaceutical products. T Source: Journal of Opioid Management (2023).
Where does this patient adherence research apply?
Pharmaceutical design, Medical device development, Pain management It sits within human factors research on designdex.org.

Related research topics

pain design research · evidence on pain · does pain improve design outcomes · patient adherence studies for designers · pain and patient adherence findings · human factors research evidence